Research Article
High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis
Table 3
Meta-analysis of the association between SNHG15 expression and clinicopathological parameters.
| Clinicopathological parameters | Study number [references] | Total sample | value | OR (95% CI) for OS | Heterogeneity | Model | I2 (%) | Ph |
| Gender (male vs. female) | 9 [18, 19, 21–27] | 847 | 0.30 | 0.87 (0.66–1.14) | 30 | 0.18 | Fixed | Tumor size (>5 cm vs. ≤5 cm) | 3 [18, 19, 25] | 317 | 0.77 | 1.17 (0.41–3.36) | 78 | 0.01 | Random | TNM stage (III-IV vs. I-II) | 9 [15, 18, 19, 22–25, 27] | 999 | <0.00001 | 3.05 (2.31–4.02) | 0 | 0.82 | Fixed | Lymph node metastasis (yes vs. no) | 8 [15, 19, 21, 23–27] | 657 | <0.00001 | 3.20 (2.30–4.45) | 0 | 0.87 | Fixed | Distant migration (yes vs. no) | 2 [19, 27] | 197 | 0.0002 | 5.05 (2.15–11.85) | 0 | 0.43 | Fixed |
|
|
OR: odds ratio; OS: overall survival; and CI: confidence interval.
|